The insurance company’s newly launched strategic fund, the result of a three-year process, will invest internationally and be stage-agnostic.
Month: March 2015
Researchers flesh out how innovation works
The hope of those carrying out the research is that it will allow them to gather informative data on how groups are pursuing innovation, filling a knowledge gap.
Qfang bites into $67m series A
Real-estate company WorldUnion is set to take a 15% stake in the online property listings platform after leading a $67m series A round.
Merck spends money on exciting Liaison
Merck has followed up a $30m investment in the data management company with funding that brought its total equity financing to $90m.
News round up 16 March 2015
A round up of all the latest news on www.globalcorporateventuring.com for our subscribers.
Weekly corporate venturing deal net: 9-13 March 2015
MySugr, an Austria-based developer of digital health treatments for diabetes, received $4.8m in seed funding from Roche Ventures, the corporate venturing unit for pharmaceutical firm Roche, and iSeed Ventures on Wednesday. The company previously raised funding from XL Health and angel investor Johann Hansmann in Feburary 2014. ThinkCerca, a US-based provider of educational tools and… Continue reading Weekly corporate venturing deal net: 9-13 March 2015
Kuiper starts Innovation Family
Corina Kuiper, who previously held a corporate venturing position at Philips, has co-founded a venture capital support organisation for corporates and startups.
Rebelle fashions series B
Second-hand designer fashion marketplace Rebelle has attracted several million euros in a funding round backed by High-Tech Gruenderfonds.
58.com decks out $200m To8to series C
Interior decoration marketplace To8to has closed a huge series C round, $34m of which was provided by e-commerce company 58.com.
Amazon calibrates 2lemetry acquisition
Salesforce-backed internet of things company 2lemetry has been bought by online retailer Amazon for an undisclosed sum.
Corporates help treat PhaseBio to $40m
Pharmaceutical company AstraZeneca led a $40m series C round for PhaseBio Pharmaceuticals, a US-based drug developer working on treatments for metabolic and specialty cardiopulmonary disorders, yesterday. The round also featured Johnson & Johnson Innovation, a network of centres owned by pharmaceutical company Johnson & Johnson that provide a range of services to companies including funding,… Continue reading Corporates help treat PhaseBio to $40m
Aduro diagnoses $86m IPO
Johnson & Johnson-backed cancer drug developer Aduro has filed for an initial public offering, following a $51.4m series D round in January.
Alibaba hitches a ride with SAIC Motor
Car manufacturer SAIC Motor and internet company Alibaba are set to invest $160m in a connected car venture that will be opened to other investors in future.
Ola revs up for $400m series E
The car and taxi marketplace will reportedly raise the cash from investor including SoftBank, the telecommunications firm it received $210m from late last year.